{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T23:16:45Z","timestamp":1792019805818,"version":"4.4.0"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,7,19]],"date-time":"2022-07-19T00:00:00Z","timestamp":1658188800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Background and Aim<\/jats:title><jats:p>Non-alcoholic fatty liver disease (NAFLD) is closely related to cardiovascular diseases (CVD). A newly proposed definition is metabolic dysfunction-associated fatty liver disease (MAFLD), which was changed from NAFLD. The clinical effect of this change on abnormalities of cardiac structure and function is yet unknown. We aimed to examine whether MAFLD is associated with left ventricular (LV) diastolic dysfunction (LVDD) and cardiac remolding and further identify the impact of different subgroups and severity of MAFLD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Method<\/jats:title><jats:p>We evaluated 228 participants without known CVDs. Participants were categorized by the presence of MAFLD and the normal group. Then, patients with MAFLD were subclassified into three subgroups: MAFLD patients with diabetes (diabetes subgroup), overweight\/obesity patients (overweight\/obesity subgroup), and lean\/normal-weight patients who had two metabolic risk abnormalities (lean metabolic dysfunction subgroup). Furthermore, the severity of hepatic steatosis was assessed by transient elastography (FibroScan<jats:sup>\u00ae<\/jats:sup>) with a controlled attenuation parameter (CAP), and patients with MAFLD were divided into normal, mild, moderate, and severe hepatic steatosis groups based on CAP value. Cardiac structure and function were examined by echocardiography.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>LVDD was significantly more prevalent in the MAFLD group (24.6% vs. 60.8%, <jats:italic>p<\/jats:italic>\u00a0&amp;lt; 0.001) compared to the normal group. The overweight subgroup and diabetes subgroup were significantly associated with signs of cardiac remolding, including interventricular septum thickness, LV posterior wall thickness, left atrial diameter (all <jats:italic>p<\/jats:italic>\u00a0&amp;lt;\u00a00.05), relative wall thickness, and LV mass index (all <jats:italic>p<\/jats:italic> &amp;lt; 0.05). Additionally, moderate-to-to severe steatosis patients had higher risks for LVDD and cardiac remolding (all <jats:italic>p<\/jats:italic>-values &amp;lt; 0.05).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>MAFLD was associated with LVDD and cardiac remolding, especially in patients with diabetes, overweight patients, and moderate-to-to severe steatosis patients. This study provides theoretical support for the precise prevention of cardiovascular dysfunction in patients with MAFLD.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2022.935390","type":"journal-article","created":{"date-parts":[[2022,7,19]],"date-time":"2022-07-19T08:02:00Z","timestamp":1658217720000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":34,"title":["Association of Metabolic Dysfunction-Associated Fatty Liver Disease With Left Ventricular Diastolic Function and Cardiac Morphology"],"prefix":"10.3389","volume":"13","author":[{"given":"Dandan","family":"Peng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenqiu","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junping","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiake","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjie","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,7,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/s41575-021-00523-4","article-title":"Advancing the Global Public Health Agenda for NAFLD: A Consensus Statement","volume":"19","author":"Lazarus","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s11883-020-0820-8","article-title":"Non-Alcoholic Fatty Liver Disease and Its Links With Inflammation and Atherosclerosis","volume":"22","author":"Abdallah","year":"2020","journal-title":"Curr Atheroscler Rep"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1111\/echo.14400","article-title":"Evaluation of Left Atrial Function in Type 2 Diabetes Mellitus Patients With Nonalcoholic Fatty Liver Disease by Two-Dimensional Speckle Tracking Echocardiography","volume":"36","author":"Chang","year":"2019","journal-title":"Echocardiography"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-020-0316-6","article-title":"From NAFLD to MAFLD: When Pathophysiology Succeeds","volume":"17","author":"Tilg","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease","volume":"158","author":"Eslam","year":"2020","journal-title":"Gastroenterology"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31420","article-title":"From NAFLD to MAFLD: Implications of a Premature Change in Terminology","volume":"73","author":"Younossi","year":"2021","journal-title":"Hepatology"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1111\/liv.14548","article-title":"Comparison of MAFLD and NAFLD Diagnostic Criteria in Real World","volume":"40","author":"Lin","year":"2020","journal-title":"Liver Int"},{"key":"B8","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1016\/j.cgh.2020.12.022","article-title":"Metabolic Dysfunction-Associated Fatty Liver Disease and Incident Cardiovascular Disease Risk: A Nationwide Cohort Study","volume":"19","author":"Lee","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.06.013","article-title":"Are the Different MAFLD Subtypes Based on the Inclusion Criteria Correlated With All-Cause Mortality","volume":"75","author":"Chen","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.2147\/DMSO.S300450","article-title":"Significant Association Between Left Ventricular Diastolic Dysfunction, Left Atrial Performance and Liver Stiffness in Patients With Metabolic Syndrome and Non-Alcoholic Fatty Liver Disease","volume":"14","author":"Parvanescu","year":"2021","journal-title":"Diabetes Metab Syndr Obes"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2018.03.027","article-title":"Nonalcoholic Fatty Liver Disease and Advanced Fibrosis are Associated With Left Ventricular Diastolic Dysfunction","volume":"272","author":"Chung","year":"2018","journal-title":"Atherosclerosis"},{"key":"B12","first-page":"65","article-title":"Preclinical Cardiac Disease in Nonalcoholic Fatty Liver Disease With and Without Metabolic Syndrome","volume":"9","author":"Makker","year":"2019","journal-title":"Am J Cardiovasc Dis"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2016.12.022","article-title":"Individual Patient Data Meta-Analysis of Controlled Attenuation Parameter (CAP) Technology for Assessing Steatosis","volume":"66","author":"Karlas","year":"2017","journal-title":"J Hepatol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2021-324243","article-title":"Diagnostic Accuracy of non-Invasive Tests for Advanced Fibrosis in Patients With NAFLD: An Individual Patient Data Meta-Analysis","volume":"71","author":"Mozes","year":"2022","journal-title":"Gut"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A New Definition for Metabolic Dysfunction-Associated Fatty Liver Disease: An International Expert Consensus Statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J Hepatol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/liv.14637","article-title":"The Association of the Steatosis Severity in Fatty Liver Disease With Coronary Plaque Pattern in General Population","volume":"41","author":"Hsu","year":"2021","journal-title":"Liver Int"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0000000000001183","article-title":"Association of Fatty Liver Index With the Risk of Incident Cardiovascular Disease and Acute Myocardial Infarction","volume":"30","author":"Olubamwo","year":"2018","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2017.03.047","article-title":"Left Ventricular Morphology and Function in Adolescents: Relations to Fitness and Fatness","volume":"240","author":"Dias","year":"2017","journal-title":"Int J Cardiol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1093\/ehjci\/jev014","article-title":"Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update From the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"16","author":"Lang","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-018-0010-0","article-title":"Risk of Cardiomyopathy and Cardiac Arrhythmias in Patients With Nonalcoholic Fatty Liver Disease","volume":"15","author":"Anstee","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"101847","DOI":"10.1016\/j.clinre.2021.101847","article-title":"NLR Contributed to the Diagnosis and Detection of Nonalcoholic Fatty Liver Disease: A Meta - Analysis","author":"Tang","year":"2021","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1111\/hepr.12770","article-title":"Effect of non-Alcoholic Fatty Liver Disease on Left Ventricular Diastolic Function and Geometry in the Korean General Population","volume":"47","author":"Jung","year":"2017","journal-title":"Hepatol Res"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.12865\/CHSJ.47.01.04","article-title":"Assessment of Left Ventricular Diastolic Function in Young Adults With Nonalcoholic Fatty Liver Disease","volume":"47","author":"Moise","year":"2021","journal-title":"Curr Health Sci J"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27869","article-title":"Association of Nonalcoholic Fatty Liver Disease With Subclinical Myocardial Remodeling and Dysfunction: A Population-Based Study","volume":"62","author":"VanWagner","year":"2015","journal-title":"Hepatology"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1055\/a-1378-4679","article-title":"Impact of Non-Alcoholic Fatty Liver Disease on Metabolic Comorbidities in Type 2 Diabetes Mellitus","volume":"130","author":"Labenz","year":"2022","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.639548","article-title":"Non-Alcoholic Fatty Liver Disease in Obese Youth With Insulin Resistance and Type 2 Diabetes","volume":"12","author":"Scapaticci","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1111\/dom.14310","article-title":"Nonalcoholic Fatty Liver Disease, Diastolic Dysfunction, and Impaired Myocardial Glucose Uptake in Patients With Type 2 Diabetes","volume":"23","author":"Lee","year":"2021","journal-title":"Diabetes Obes Metab"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgab641","article-title":"Association of MAFLD With Diabetes, Chronic Kidney Disease, and Cardiovascular Disease: A 4.6-Year Cohort Study in China","author":"Liang","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.017371","article-title":"Cardiac Morphology, Function, and Hemodynamics in Patients With Morbid Obesity and Nonalcoholic Steatohepatitis","volume":"10","author":"Styczynski","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.4093\/dmj.2019.0001","article-title":"Association Between Non-Alcoholic Steatohepatitis and Left Ventricular Diastolic Dysfunction in Type 2 Diabetes Mellitus","volume":"44","author":"Lee","year":"2020","journal-title":"Diabetes Metab J"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1002\/oby.21879","article-title":"Nonalcoholic Steatohepatitis is Associated With Cardiac Remodeling and Dysfunction","volume":"25","author":"Simon","year":"2017","journal-title":"Obes (Silver Spring)"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.4093\/dmj.2020.0127","article-title":"Response: Association Between Non-Alcoholic Steatohepatitis and Left Ventricular Diastolic Dysfunction in Type 2 Diabetes Mellitus (Diabetes Metab J 2020;44:267-76)","volume":"44","author":"Lee","year":"2020","journal-title":"Diabetes Metab J"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1017\/S104795112000445X","article-title":"Three-Dimensional Speckle Tracking Echocardiography for Early Detection of Left Ventricular Dysfunction in Children With non-Alcoholic Fatty Liver Diseases","volume":"31","author":"El Amrousy","year":"2021","journal-title":"Cardiol Young"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i27.9055","article-title":"Nonalcoholic Fatty Liver Disease and the Heart in Children and Adolescents","volume":"20","author":"Pacifico","year":"2014","journal-title":"World J Gastroenterol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2014.11.030","article-title":"Epicardial Fat, Cardiac Geometry and Cardiac Function in Patients With Non-Alcoholic Fatty Liver Disease: Association With the Severity of Liver Disease","volume":"62","author":"Petta","year":"2015","journal-title":"J Hepatol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.5152\/akd.2014.5212","article-title":"Non Alcoholic Steatohepatitis is Associated With Subclinical Impairment in Left Ventricular Function Measured by Speckle Tracking Echocardiography","volume":"15","author":"Baktir","year":"2015","journal-title":"Anatol J Cardiol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2018.10.027","article-title":"Relation of Hepatic Fibrosis in Nonalcoholic Fatty Liver Disease to Left Ventricular Diastolic Function and Exercise Tolerance","volume":"123","author":"Canada","year":"2019","journal-title":"Am J Cardiol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1177\/0003319715576672","article-title":"Epicardial Fat in Nonalcoholic Fatty Liver Disease: Properties and Relationships With Metabolic Factors, Cardiac Structure, and Cardiac Function","volume":"67","author":"Psychari","year":"2016","journal-title":"Angiology"},{"key":"B39","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1161\/CIRCULATIONAHA.107.728550","article-title":"Diastolic Stiffness of the Failing Diabetic Heart: Importance of Fibrosis, Advanced Glycation End Products, and Myocyte Resting Tension","volume":"117","author":"van Heerebeek","year":"2008","journal-title":"Circulation"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2016.06.206","article-title":"Insulin Resistance-Associated Decreases in Left Ventricular Diastolic Function are Strongly Modified by the Extent of Concentric Remodeling in a Community Sample","volume":"220","author":"Peterson","year":"2016","journal-title":"Int J Cardiol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"491","DOI":"10.2147\/RMHP.S285880","article-title":"MAFLD Criteria Guide the Subtyping of Patients With Fatty Liver Disease","volume":"14","author":"Huang","year":"2021","journal-title":"Risk Manag Healthc Policy"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.5551\/jat.40956","article-title":"A High-Fat and High-Cholesterol Diet Induces Cardiac Fibrosis, Vascular Endothelial, and Left Ventricular Diastolic Dysfunction in SHRSP5\/Dmcr Rats","volume":"25","author":"Watanabe","year":"2018","journal-title":"J Atheroscler Thromb"},{"key":"B43","doi-asserted-by":"publisher","first-page":"S1542-3565(22)00001-5","DOI":"10.1016\/j.cgh.2021.12.043","article-title":"Association of Physical Activity With Risk of Liver Fibrosis, Sarcopenia, and Cardiovascular Disease in NAFLD","volume":"6","author":"Chun","year":"2022","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.935390\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,19]],"date-time":"2022-07-19T08:02:04Z","timestamp":1658217724000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.935390\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,19]]},"references-count":43,"alternative-id":["10.3389\/fendo.2022.935390"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2022.935390","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,19]]},"article-number":"935390"}}